Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>Magnetic resonance‐guided radiation therapy (MRgRT) has shown great promise for localization and real‐time tumor monitoring. However, to date, quantitative imaging has been limited for low field MRgRT. This work benchmarks quantitative T1, R2* and Proton Density (PD)‐mapping in phantom on a 0.35T MR‐linac and implements a novel acquisition method, <b>ST </b>rategically <b>A </b>cquired <b>G </b>radient <b>E </b>cho (STAGE). To further validate STAGE in a clinical setting, a pilot study was undertaken in a cohort of brain tumor patients to elucidate opportunities for longitudinal functional imaging with an MR‐linac in the brain. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>STAGE (two triple‐echo gradient echo (GRE) acquisitions) was optimized for a 0.35T low‐field MR‐linac. Simulations were performed to choose two flip angles to optimize signal‐to‐noise ratio (SNR) and T1‐mapping precision. Tradeoffs between SNR, scan time, and spatial resolution for whole‐brain coverage were evaluated in healthy volunteers. Data were inputted into a STAGE processing pipeline to yield 4 qualitative images (T1‐weighted, enhanced T1‐weighted, proton‐density (PD) weighted, and simulated FLuid‐Attenuated Inversion Recovery (sFLAIR)), and 3 quantitative datasets (T1, PD, and R2*). A benchmarking ISMRM/NIST phantom consisting of vials with variable NiCl<sub>2</sub> and MnCl<sub>2</sub> concentrations was scanned using variable flip angles (VFA) (2‐60 degrees) and inversion recovery (IR) methods at 0.35T. STAGE and VFA T1 values of vials were compared to IR T1 values. As measures of agreement with reference values and repeatability, relative error (RE) and coefficient of variability (CV) were calculated, respectively, for quantitative MR values within the phantom vials (spheres). To demonstrate feasibility, longitudinal STAGE data (pre‐treatment, weekly, and ~2 months post‐treatment) were acquired in an IRB‐approved pilot study of brain tumor cases via the generation of temporal and differential quantitative MRI maps. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>In the phantom, RE of measured STAGE and VFA T1 relative to IR reference values were 7.0 ± 2.5% and 9.5 ± 2.2%, respectively. RE for the PD vials was 8.1%±6.8% and CV for phantom R2* measurements was 10.1% ± 9.9%. Simulations and volunteer experiments yielded final STAGE parameters of FA=50°/10°, 1x1x3 mm<sup>3</sup> resolution, TR=40ms, TE=5/20/34ms in 10 minutes (64 slices). In the pilot study of brain tumor patients, differential maps for R2* and T1 maps were sensitive to local tumor changes and appeared similar to 3T follow up MRI datasets. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>Quantitative T1, R2*, and PD mapping are promising at 0.35T agreeing well with reference data. STAGE phantom data offer quantitative representations comparable to traditional methods in a fraction of the acquisition time. Initial feasibility of implementing STAGE at 0.35T in a patient brain tumor cohort suggests that detectable changes can be observed over time. With confirmation in a larger cohort, results may be implemented to identify areas of recurrence and facilitate adaptive radiation therapy.</p></section>

Quantitative MRI using STrategically Acquired Gradient Echo (STAGE): optimization for 1.5 T scanners and T1 relaxation map validation

Sequence for T1 and T2 Mapping in Low Field Magnetic Resonance Imaging

Three-dimensional Simultaneous Brain Mapping of T1, T2, T2*and Magnetic Susceptibility with MR Multitasking

STrategically Acquired Gradient Echo (STAGE) Imaging, Part III: Technical Advances and Clinical Applications of a Rapid Multi-Contrast Multi-Parametric Brain Imaging Method.

STrategically Acquired Gradient Echo (STAGE) Imaging, Part I: Creating Enhanced T1 Contrast and Standardized Susceptibility Weighted Imaging and Quantitative Susceptibility Mapping.

Three-dimensional simultaneous brain T 1 , T 2 , and ADC mapping with MR Multitasking.

3D Isotropic Resolution Diffusion-Prepared Magnitude-Stabilized Bssfp Imaging with High Geometric Fidelity at 1.5 Tesla

Rapid multicontrast brain imaging on a 0.35T MR‐linac

STrategically Acquired Gradient Echo (STAGE) Imaging, Part II: Correcting for RF Inhomogeneities in Estimating T1 and Proton Density.

Three-dimensional simultaneous brain T<sub>1</sub>, T<sub>2</sub>, and ADC mapping with MR Multitasking

Rapid three-dimensional multiparametric MRI with quantitative transient-state imaging

Fetal brain tissue characterization at 1.5 T using STrategically Acquired Gradient Echo (STAGE) imaging

Multi-Echo Quantitative Susceptibility Mapping for Strategically Acquired Gradient Echo (STAGE) Imaging

Fast T1 Mapping MRI in Preclinical and Clinical Settings Using Subspace-Constrained Joint-Domain Reconstructions

Quantitative brain T1 maps derived from T1-weighted MRI acquisitions: a proof-of-concept study

A three-dimensional MR-STAT protocol for high-resolution multi-parametric quantitative MRI

Stochastic Gradient Langevin dynamics for joint parameterization of tracer kinetic models, input functions, and T1 relaxation-times from undersampled k-space DCE-MRI

Rapid high-resolution T1 mapping using a highly accelerated radial steady-state free-precession technique

Comparison and calibration of MP2RAGE quantitative T1 values to multi-TI inversion recovery T1 values

Improvements in Between‐Vendor MRI Harmonization of Renal T2 Mapping using Stimulated Echo Compensation

Strategically Acquired Gradient Echo (STAGE) Imaging, Part IV: Constrained Reconstruction of White Noise (CROWN) Processing As a Means to Improve Signal-to-Noise in STAGE Imaging at 3 Tesla.